Payment Rates for Medicaid Home Care in 2026

Authors: Priya Chidambaram, Alice Burns, and Molly O'Malley Watts
Published: Nov 20, 2026

Long-standing workforce challenges in Medicaid home care, also known as home- and community-based services (HCBS), affect care for the more than 5 million people who use these services. Shortages and high turnover rates among the direct care workforce reflect demanding work and low wages, particularly among home care workers (who are direct care workers that provide HCBS). This issue brief describes states’ ongoing efforts to respond to shortages of home care workers and how they pay these workers, finding that increased payment rates are a key component of states’ efforts to address workforce shortages.

Workforce shortages may worsen in future years because of a decreasing pool of available workers on account of changes in immigration policy, changes in federal policy from the 2025 reconciliation law, and new pressure on states to cut Medicaid spending. Nearly one in three home care workers are immigrants, and the Trump Administration’s intensified immigration enforcement and restrictive policies are deepening anxiety and fear among immigrants of all statuses, with survey data finding that some immigrants are avoiding work on account of those changes. States may also face pressure to reduce Medicaid spending as state fiscal conditions tighten because of slower revenue growth, increased spending pressures, and substantial reductions in federal Medicaid spending from the 2025 reconciliation law.

However, states’ goals to reduce Medicaid spending may be at odds with new administrative requirements that potentially limit states’ abilities to reduce payment rates for home care workers. During a public webinar that the Centers for Medicare and Medicaid Services (CMS) hosted to share more information on payment transparency requirements in the 2024 Access Rule (see Appendix Box 1 for more details), CMS noted that proposed rate reductions for home care workers might not be approved if they would cause more than a four percent decrease in Medicaid expenditures for any service category. CMS did not specify the rationale for this condition, though it could be to maintain access to services. Changes in federal policy surrounding program integrity, including issues related to provider revalidation, could also further strain the home care workforce.  

Amidst this evolving landscape, this issue brief describes Medicaid payment rates for home care and other workforce supports that are in place in 2026, and how KFF’s data on payment rates compare to the data states are now required to report under payment reporting requirements in the Medicaid Access rule. The data come from the 24th KFF survey of officials administering Medicaid home care programs in all 50 states and the District of Columbia (hereafter referred to as a state), which states completed between April and August 2026. The survey was sent to each state official responsible for overseeing home care benefits (including home health, personal care, and waiver services for specific populations, such as people with physical disabilities). All states except Florida and South Carolina responded to the 2026 survey, but response rates for certain questions were lower. South Carolina’s payment rate data from the 2025 survey was also included with their permission to provide a more comprehensive national picture of payment rates to Medicaid home care providers.

Key takeaways include:

  • All responding states reported taking actions to address workforce shortages, though fewer states reported increasing provider compensation when compared with 2025 (Figure 1).
  • All responding states reported shortages of home care workers, most frequently among nursing staff, direct support professionals, personal care attendants, home health aides, and case managers (Figure 2).
  • States reported that high turnover, low wages, and increased demand for home care were the most common factors contributing to increasing workforce shortages.
  • Most (43) states reported permanent closures of home care providers within the last year (Figure 3).
  • States are now reporting detailed payment rates for home care online, but the data are difficult to compare across states. In contrast, KFF data represent statewide average payment rates, which are less detailed but facilitate comparisons across states.
  • Among the 29 states that reported time-based payment rates for personal care providers, more than half pay less than $20 per hour (Figure 5).
The bar chart compares the number of states reporting each strategy to increase the number of workers in home and community-based services programs. Increasing provider payment rates is states' most common strategy to increase the supply of these workers, followed by offering education and training.

How Are States Addressing the Workforce Challenges in Home Care?

All responding states reported workforce shortages in 2026, with the most common shortages being among nursing staff (47 states), direct support professionals (46 states), and personal care attendants (45 states) (Figure 2, Appendix Table 2). States were asked if they had shortages of each type of provider but were not provided with a definition of “shortage.” Most states also reported shortages of home health aides (42 states), case managers (41 states), certified nurse aides (40 states), community-based mental health providers (36 states), and occupational, physical, and speech therapy providers (31 states). In some cases, states may not have reported a shortage of a particular type of provider because that type of service is not offered through their home care program. Nearly all responding states (48) reported shortages for more than one type of provider, and 45 states reported shortages among five or more provider types.

All Responding States Reported Shortages of Home Care Workers in 2026 (Bar Chart)

Most states (43) reported increasing shortages of home care workers in 2026 relative to 2025, with high turnover (38 states), low wages (36 states), and increased demand for home care services (30 states) ranked as the most common factors contributing to increased shortages. States were asked whether they experienced increasing shortages of home care workers in the last year and, if yes, what factors may be contributing to the worsening shortages. Four states acknowledged the same level of shortages as the previous year (Ohio, Tennessee, Texas, and Utah), while two states (New Hampshire and Virginia) noted that the trend was unknown. When ranked by priority, low wages relative to other sectors was the top factor contributing to the shortages. States reported other challenges to building the home care workforce, including changes in immigration enforcement, lack of benefits, increasing job responsibilities, an aging workforce exiting the labor pool, and provider shortages in rural areas. Some state officials provided comments that underscored workforce challenges:

“With inflation rising and low reimbursement rates for providers, it is difficult for [agencies] to offer competitive salaries for workers to retain qualified professional staff.”

“[There is] high HCBS employee workforce turnover rate, ranging from 29%–48% for direct support workers alone. [There is also a] lack of benefits, with roughly only a quarter of providers offering benefits to their employees, and salaries not keeping pace with inflation.”

“There are not enough workers interested in providing self-directed services to meet the growing needs of families.”

Within the last year, 43 states reported permanent closures of home care providers, which were most common among adult day health programs (29 states), enrollees’ homes (26 states), assisted living facilities (24 states), and group homes (23 states) (Figure 3, Appendix Table 3). States were asked if there were any permanent closures of providers that offer services for Medicaid enrollees based on the location in which the providers deliver care. For a setting such as an assisted living facility or group home, a closure could reflect either the closure of an assisted living facility or the closure of a home care agency that sent workers into facilities and group homes. States were not asked to provide a reason for the closures. Some states reported closures of home health agencies (14 states), supported employment providers (11 states), and community mental health providers (8 states). Most states (38) reported closures among more than one type of provider, and 30 states reported closures among three or more provider types.

Forty-Three States Reported Permanent Closures of Medicaid Home Care Providers in 2026 (Bar Chart)

All responding states reported taking actions to address provider shortages, with 39 states increasing provider payment rates and 37 states developing or expanding worker education and training programs (Figure 1). Smaller numbers of states reported establishing or raising a state minimum wage requirement for HCBS workers (19 states), offering paid sick leave (19 states), offering incentive payments to recruit or retain workers (15 states), and offering workers retention bonuses (9 states).

Compared with 2025, fewer states reported increasing provider compensation in 2026 (Figure 1). The number of states that reported increasing provider payment rates dropped from 48 in 2025 to 39 in 2026, while the number of states that reported offering incentive payments to recruit or retain workers dropped from 24 to 15, and the number of states that reported offering retention bonuses dropped from 20 to 9. There were minimal changes in the number of states that reported other initiatives between 2025 and 2026, suggesting that the reduced number of states offering higher compensation (which is a direct cost increase for the states) may reflect states’ more tenuous fiscal climate.

All but 11 states use managed care to provide at least some home care, and in 15 of the states with managed care, fee-for-service payment rates impact the payment rates that managed care plans pay home care providers. Out of the 40 states that use managed care to provide at least some home care, 14 states reported that the fee-for-service payment rates represent the minimum amount that plans must pay providers, 1 state (Wisconsin) reported that the rate represents the maximum payment rate for managed care plans, 9 states reported that the fee-for-service rates do not affect payments by private plans, and 2 states responded that the answer was unknown or did not respond to the question.

How Much Do States Pay for Medicaid Home Care?

The paragraphs in this section provide information on the payment rates collected from KFF’s survey of Medicaid home care programs. States are now required to report some Medicaid home care payment rates on state websites, per the provisions in the 2024 Medicaid Access Rule. While the publicly reported data are much more detailed than KFF’s survey data (often including payment rates by procedure code, sub-state geography, or population type), the data are difficult to compare payment rates across services, worker types, and states. See Appendix Box 1 for more information on these requirements and how the publicly reported data differ from data reported to KFF.  

KFF asked states to report their average hourly rate paid to two types of home care provider agencies (personal care agencies and home health agencies) and three types of specific home care providers (personal care providers, home health aides, and registered nurses), but many states were unable to report all rates (Appendix Table 4). The number of states that responded to the KFF survey but did not provide hourly payment rates or reported that payment rates were unknown was 2 for personal care agencies and 29 for home health agencies. Many states also did not provide payment rates for specific provider types: For registered nurses and home health aides, more than half of states did not provide hourly payment rate information or reported that payment rates were unknown. Among the states that were able to report payment rates in the KFF survey, only 15 could report payment rates for personal care agencies, home health agencies, personal care providers, and home health aides. Those 15 states include states that reported a mix of hourly and non-hourly rates for these services. 

States reported many reasons why it was difficult to report payment rates, including the following:

  • Some states reported that services were bundled together in various ways, and therefore the payment rates were not distinguishable.
  • Among states with managed care, some states responded that they did not know the payment rates for agencies because the services were paid for by managed care plans and they did not have access to those payment rates.
  • Other states responded that they knew the payment rates for agencies but not what the agencies paid their home care workers.

In addition to having difficulty reporting payment rates, many states reported different payment rates for personal care across different waivers, and the waiver payment rates often differ from the payment rates for personal care provided through the state plan. When states reported multiple payment rates for personal care, KFF used the median of those payment rates in the analysis.

The payment rates to home care providers show considerable variation and are somewhat higher than those reported by other organizations, which may reflect differences in reporting and provider categorization (Figure 4). KFF’s survey estimates that median payment rates to providers are $19 per hour for personal care providers, $42 for home health aides, and $64 for registered nurses. It is difficult to compare those numbers to other sources of data for the following reasons:

  • Other organizations group classes of providers together differently. The Bureau of Labor Statistics reports $17 per hour for home health and personal care aides in 2025.
  • Other organizations include payment rates for workers regardless of the source of payment, whereas KFF rates only reflect the Medicaid rates. Medicaid often covers more intensive personal care services than other payers, which may contribute to the higher rates.

Payment rates to home health agencies are generally higher than those to personal care agencies, but there is considerable variation in both (Figure 4). Among states reporting hourly rates, the rates for home health agencies range from $20 to $268, whereas those for personal care agencies range from $18 to $51. Those states reported that the median hourly payment to home health agencies was $51 and $27 for personal care agencies. Between 2025 and 2026, the median payment rates for personal care agencies and home health aides increased marginally ($26 to $27 and $41 to $42), while median payment rates for personal care providers and home health agencies stayed the same ($19 and $51, respectively) and median payment rates for registered nurses decreased ($70 to $64).

There Is Considerable Variation in Payment Rates for Medicaid Home Care Across States and Provider Types (Dot Plot)

Among states able to report any payment rate data, payments for personal care workers range from below $15 to over $25 per hour (Figure 5, Appendix Table 4). Rates for home health aides are somewhat higher than those of personal care workers, reflecting the additional training requirements for such workers. Among the states with payment rates for home health aides in the highest category, some states reported that the rates were per visit or per day (which is noted in Appendix Table 4). There were other states with particularly high payment rates that did not report providing rates per visit or per day, but the rates may still reflect a non-hourly payment basis.

Payment Rates for Home Care Vary Across States and Provider Types (Choropleth map)

Appendix Box 1: What Does the Medicaid Access Rule Require and How Do the Publicly Reported Data Compare to the KFF Survey Data?

What does the Access Rule require?

To improve transparency around home care payment rates, the 2024 Access Rule required states to publish payment rates on their websites starting July 2026. The home care requirements are a subset of requirements in the rule related to Medicaid fee-for-service rates. The provisions from the rule that went into effect on July 2026 require states to report hourly payment rates for personal care, home health aide, homemaker, and habilitation services on state websites; and to identify the number of Medicaid-paid claims and number of Medicaid enrollees who received services within a calendar year. During a public webinar, CMS specified that states must also report proposed rate reductions for 1915(c) waivers (states’ most common approaches for providing home care) to CMS.

Starting in July 2028, another provision of the Access Rule requires states to report the percent of total Medicaid payments for personal care, home health aide, homemaker, and habilitation services that is spent on compensation for direct care workers. Recent guidance released by the federal government provides more information on how states may define the specified services, direct care workers, and compensation. Fee-for-service reporting requirements begin July 9, 2028 and managed care requirements apply to rating periods beginning on or after July 9, 2028. States must report on their readiness to comply with this requirement by July 2027. This requirement was intended to help address workforce shortages, and the rule specifies that states are to ensure that at least 80% of total Medicaid payments are going to direct care worker compensation by July 2030, a requirement informally known as the 80/20 rule. The recent guidance did not mention any requirements for states to begin planning for the 80/20 rule.

How do the publicly reported data on payment rates compare to the KFF survey data?

KFF reviewed the publicly reported data from just under half of states and found that the publicly reported data from states under the access rule differ from KFF survey data in several respects. Generally speaking, the publicly reported data provide more detail than the KFF survey data, which may be useful for understanding within-state variation in payments, but also makes it difficult to compare payment rates across states. Specifically:

  • KFF data on payment rates are standardized across states to the greatest extent possible and can be downloaded in 50-state tables, whereas state-reported data on payment rates are not standardized in either format or content, which makes it difficult to compare across states. In both the KFF data and the state-reported data, however, some states reported some payment rates per day or per visit rather than per hour, while other states reported hourly rates.
  • KFF asks states to provide average payment rates across the state, but the state-reported data may differ by geographic region. For example, Colorado reports different rates for Denver and non-Denver areas, while North Carolina reports state-level rates.
  • KFF asks states to provide the average payment rate across all services provided within a waiver or state plan benefit, but state-reported data often show payment rates by specific procedure code or service type (e.g. Illinois).
  • KFF did not ask states to provide the number of people using each service or the number of services delivered, but states are also required to report this information at the procedure code level. KFF relies on claims data for counts of home care users, but does not use procedure codes, so comparison to public data is challenging.
States' Use of Strategies to Increase the Number of Medicaid Home Care Workers in 2026 (Table)
States' Responses to Whether They Were Experiencing Workforce Shortages by Type of Worker in 2026 (Table)
States Reporting Permanent Closures of Home Care Providers in 2026, by the Location in Which Services are Offered (Table)
States' Hourly Payment Rates for Home Care Agencies and Workers in 2026 (Table)

Medicaid’s Home Care Support for Family Caregivers in 2026

Authors: Alice Burns, Abby Wolk, and Molly O'Malley Watts
Published: Nov 20, 2026

KFF estimates that 5.3 million Medicaid enrollees use home care, which provides medical and supportive services to help people with the activities of daily living (such as eating and bathing) and the instrumental activities of daily living (such as preparing meals and managing medications). Medicare generally does not cover home care (also known as home- and community-based services, or HCBS), and Medicaid paid for two-thirds of home care spending in the U.S. in 2023.

In Medicaid home care, many people “self-direct” their services, giving them greater autonomy over the types of services provided and who they are provided by and, in some cases, allowing payments to family caregivers. Payments for caregiving can help mitigate the financial struggles family caregivers experience when they are forced to reduce their hours of work or quit their jobs on account of their caregiving duties. KFF focus groups of caregivers found that family caregivers often reported struggling to make ends meet and having to reduce the hours they work at other jobs due to the demands of caregiving. A 2026 AARP Caregiving Out-of-Pocket Costs study found that the costs of caregiving are nearly one third of average household incomes and are even higher for lower income individuals and those with complex care needs. Self-directed services can also help address shortages of paid home care workers, which can be one of the factors placing additional strain on family caregivers. Beyond paying for their caregiving, Medicaid supports family caregivers with services such as training, support groups, and respite care (which is paid care that allows family caregivers to take a break from their normal responsibilities).   

Heading into 2027, there are multiple factors pressuring states to reduce Medicaid supports for family caregivers, including slower state revenue growth, substantial changes to Medicaid financing from the 2025 reconciliation law, and the federal government’s efforts to address Medicaid program integrity, including a focus on home care (with paused federal reimbursement for some home care programs in two states). Although program integrity efforts have focused on provider organizations potentially engaged in fraud, the delivery of services in people’s homes and payments to family and friends, who are not otherwise registered as Medicaid providers, has increased scrutiny over Medicaid supports for family caregivers. In response, recent tracking of programmatic changes to Medicaid home care shows several proposed cuts were to programs supporting family caregivers.

Amidst this background, this issue brief describes the availability of self-directed services and supports for family caregivers in Medicaid home care in 2026. The data come from the 24th KFF survey of officials administering Medicaid home care programs in all 50 states and the District of Columbia (hereafter referred to as a state), which states completed between April and August 2026. The survey was sent to each state official responsible for overseeing home care benefits (including home health, personal care, and waiver services for specific populations such as people with physical disabilities). All states except Florida and South Carolina responded to the 2026 survey, but response rates for certain questions were lower. South Carolina’s responses to the 2025 survey were included with their permission. Survey findings are reported by state and waiver target population, although states often offer multiple waivers for a given target population. Key findings include:

  • All responding states except Alaska allow Medicaid enrollees to self-direct their home care in at least some circumstances, and among those states, all allow enrollees to select, train, and dismiss their caregivers and set caregiver worker schedules.
  • All responding states pay family caregivers under some circumstances and provide family caregivers with other types of support, including respite care (Figure 1).
  • Family caregiver supports are most widely available for caregivers of people with intellectual or developmental disabilities (I/DD).
  • Despite concerns about cuts to Medicaid supports for family caregivers, in 2026, most supports stayed the same as in the prior year, and a few states increased their supports.
All Responding States Pay Family Caregivers Under Some Circumstances (Stacked Bars)

How Many States Allow Medicaid Enrollees to Self-Direct Their Home Care?

Nearly all states allow Medicaid enrollees to self-direct their home care in some circumstances (Figure 2, Appendix Table 2). Self-direction came out of the “consumer-directed” movement for personal care services that started with demonstration programs in 19 states, funded through grants from the Robert Wood Johnson Foundation. Today, states may give people the option to self-direct home care through a wide variety of optional home care programs. States most frequently allow self-direction in waivers that serve people with I/DD, followed by adults ages 65 and older or those with physical disabilities. Among the 50 states responding to KFF’s survey, Alaska is the only state that reported not permitting self-direction under any of its home care programs. 

While all responding states, except Alaska, allow self-direction under at least one waiver or program, some states expanded self-direction in specific waivers or programs between 2025 and 2026. Four states newly allowed self-direction in 2026: Indiana, in its waivers for people with I/DD and for people with traumatic brain and/or spinal cord injuries; New York, in its waivers for adults ages 65 and older and people with physical disabilities; New Mexico, in its waiver for medically fragile and technology-dependent children; and D.C., under its state plan personal care benefit.

Nearly All States Allow Individuals to Self-Direct Home Care Under at Least One Program (Stacked Bars)

Among states that authorize self-direction, all states allow enrollees to select, train, and dismiss workers and set caregiver worker schedules (Figure 3, Appendix Table 3, Appendix Table 4). The ability to select, train, and dismiss workers is referred to as “employer authority” because it allows Medicaid enrollees (with the help of their designated representatives when appropriate) to decide who will be caring for them. All states with self-directed services programs provide employer authority to enrollees (Box 1). Additionally, all states allow individuals to hire independent providers (e.g., people who are not otherwise registered as Medicaid providers) for home care services.

Box 1. Example of Employer Authority

Helen is an 85-year-old women who lives alone and who has had a stroke. Following the stroke, she now requires assistance with activities of daily living. Helen’s state allows people to hire caregivers of their choosing, and under some conditions, family members. Helen elects to self-direct her care and chooses to hire her adult daughter, Emily, to be her caregiver. Due to her mother’s condition, Emily quits her job to care for her mom. Emily enrolls with the state and completes the required paperwork. The state is responsible for setting Emily’s hourly wage and number of authorized hours. The state approves 7 hours/day of paid caregiving. Helen determines that Emily will provide all 7 hours of care and assigns her tasks, abiding by the guidelines set by the state. Each week, Emily submits her time sheet to the state, who pays Emily and handles all withholding and taxes.

Among states that authorize self-direction, most states allow enrollees to establish payment rates for their caregivers (40) and to determine how much Medicaid funding is spent among the various authorized services (39) (Figure 3). Those abilities are referred to as “budget authority” because they give enrollees the power to decide how Medicaid funds are spent within an approved budget (Box 2).

Box 2. Example of Employer Authority and Budget Authority

Jason, a 32-year-old man, has a spinal cord injury and now requires a caregiver. Jason’s state allocated him a set budget per month to spend on caregiving and related expenses, but it’s up to Jason how to spend that money. Jason’s state contracts with a third party or organization (e.g., a “fiscal intermediary”) to help care recipients with required paperwork and to complete tasks such as tracking caregiver hours and paying caregivers. Through the fiscal intermediary, Jason develops a spending plan for his monthly allotment and hires a caregiver from a local home care organization that is registered with Medicaid. Jason and his hired caregiver, Steve, complete all paperwork required by the state’s approved fiscal intermediary. Since Jason’s program offers budget authority, Jason gets to decide the hourly wage and hours for Steve. After allocating money for Steve’s wages, Jason can use any extra allocated money to purchase additional approved supports that were included in his spending plan, such as meal delivery services on days that his caregiver does not work, and respite care, so his wife, who provides unpaid care outside of Steve’s hours, can have a break. Each month, Steve submits his hours to the fiscal intermediary. The fiscal intermediary is responsible for paying Steve and ensuring that Jason’s total spending stays within budget.

All states allowing self-direction provide financial management services to enrollees, and all but Mississippi and Nebraska use fiscal intermediaries to do so. When states offer budget authority, federal rules require them to provide participants with assistance in understanding billing and documentation requirements, performing payroll duties (which includes paying taxes and workers compensation), purchasing goods and services, and tracking expenditures to make sure spending is within the budget. Beyond that, care recipients often need help with finding caregivers and other services, and determining how to decide what services they need and in what amounts. A range of entities support beneficiaries in self-directing their care (see Figure 1, from the Medicaid and CHIP Payment and Access Commission). Nearly all states rely on outside organizations to help with the services, and all but Mississippi and Nebraska rely on fiscal intermediaries to handle tracking expenditures. In Mississippi, the state’s Department of Rehabilitation Services provides these functions and manages payroll for enrollees. In Nebraska, the state Medicaid agency serves as the employer/fiscal agent and directly handles financial management functions for individuals who self-direct. In many cases, Medicaid expenditures are paid directly to the fiscal intermediary or a state or local government unit assisting enrollees, and the third party pays providers.

While nearly all responding states allow Medicaid enrollees to self-direct their home care, the number of individuals doing so is unknown. KFF asked states, “What percentage of people are self-directing services under this waiver?” States could choose from five options: less than 25%, 25%–50%, 51%–75%, more than 75%, or unknown. Over half of states under each waiver type or state plan program did not report a percentage. Among programs that did respond, most reported that less than 25% of people are self-directing care.

All States with Self-Directed Home Care Programs Allow Enrollees to Select Their Caregivers (Bar Chart)

How Many States Pay Family Caregivers and Through Which Home Care Programs?

All responding states pay family caregivers through one or more Medicaid home care program (Figure 1, Appendix Table 1). Family caregivers can generally be paid to provide personal care, which may be offered through several different types of Medicaid home care programs. Personal care may be provided through waivers such as the 1115 or 1915(c) programs, through the Medicaid state plan, or through a combination of both. Waiver services tend to encompass a wider range of benefits than the state plan benefit, but waivers are usually restricted to specific groups of Medicaid enrollees based on geographic region, income, or type of disability, and are often available only to a limited number of people, resulting in waiting lists. 

All responding states allow payments to family and friends through one or more waiver programs, but fewer states allow payments to legally responsible relatives. Forty-four states allow payments to legally responsible relatives through waiver programs. Payments to legally responsible relatives are less common than those to other family and friends because of additional legal requirements that apply to those payments (Box 3). In 2026, Nebraska started newly permitting payments to legally responsible relatives in its waivers for people with I/DD and for adults ages 65 and older and people with physical disabilities.

Payments to family caregivers are less common through the state plan—allowed by 25 states for other family and friends and by 7 states for legally responsible relatives. States pay family caregivers through the state plan less frequently because fewer states offer personal care through the state plan and because the legal requirements governing state plan services are more restrictive than those governing waiver services. One state, Nebraska, newly started allowing payments to legally responsible adults through the state plan in 2026.

Box 3: What Are the Legal Requirements for Paying Family Caregivers?

Medicaid laws have more complicated requirements for states to pay legally responsible relatives than is the case for other types of family and friend caregivers. The specific legal requirements for paying family caregivers are complicated and differ across home care programs: 

• For personal care offered through the state plan using section 1905 authority, there is a federal prohibition on paying for services provided by spouses and parents of minor children (who make up most, but not all, legally responsible relatives). Other family and friends may be paid if they meet applicable provider qualifications, there are strict controls on the payments, and the provision of care is justified (which can be done when there is a lack of other qualified providers in the area). 

• For home care offered through waiver programs, the requirements governing payments to family and friends are similar to those governing personal care through section 1905 authority. A key difference is that states may pay legally responsible relatives when the services being provided are “extraordinary care,” which is defined as care that exceeds the range of activities a legally responsible relative would ordinarily perform and is necessary to ensure health and welfare and to avoid institutionalization. 

• For personal care offered through the state plan under sections 1915(i), (j), or (k), states may pay legally responsible relatives using criteria similar to those of the waiver programs. However, some of those authorities designate a family member to be the recipient’s legal representative and may prohibit payments to legal representatives.  

Payments for family caregivers are most common under waivers for people with I/DD (Figure 4, Appendix Table 5). Among the 47 states that responded to the survey and have waivers for people with I/DD, all 47 allow payments to family caregivers. There are fewer states with other types of waivers, and not all the other waivers allow payments to family caregivers. Among the 45 responding states with waivers for adults ages 65 and older and those with physical disabilities, 41 pay family caregivers, and among the 21 states with waivers for people with traumatic brain and/or spinal cord injuries, 18 do.

Among Waivers and Programs, States Are Most Likely to Pay Family Caregivers for People with Intellectual or Developmental Disabilities (Stacked Bars)

While all responding states allow payments to family caregivers, it is unknown what percentage of waiver participants are receiving paid care from family caregivers. KFF asked states, “What percentage of waiver recipients are receiving paid care from their legally responsible relatives/family members who are not legally responsible relatives?” Over half of states did not report the percentage of waiver recipients receiving paid care from either legally responsible relatives or other family members or friends. It is also unknown how often people with paid family caregivers also receive other paid care.

While most states allow family members to be paid caregivers, states do not collect much information about those caregivers. KFF asked states whether they track information on family caregivers’ name, age, income, and Medicaid eligibility. Just over half of states collected information about family caregivers, with most of the data collected focused on paid caregivers’ names and ages. Very few states collected any information on unpaid caregivers. Only 14 states reported knowing how many paid and/or unpaid caregivers were providing services to waiver participants and even fewer (7 states) knew if family caregivers were enrolled in Medicaid through the Affordable Care Act (ACA) expansion. Starting January 1, 2027, people who are eligible for Medicaid through the ACA expansion will be required to meet new community engagement requirements. Caring for a family member with a disability can count towards the work requirement minimum hours or qualify caregivers for an exemption from the requirement. However, the lack of data on caregivers’ Medicaid eligibility will likely increase the paperwork burden on family caregivers who are subject to work requirements because they will be required to provide documentation showing they are meeting the requirements or qualify for an exemption.

In most cases, family caregivers receive hourly wages like those of other employees, but 12 states have adopted programs known as structured family caregiving, in which family members are paid a per diem rate (Appendix Table 6). Structured family caregiving is a Medicaid benefit that supports unpaid caregivers of people who use Medicaid home care through waiver programs. In the structured program, Medicaid pays provider agencies a daily stipend for participants. The agency is responsible for directing a care coordinator or social worker and a nurse to oversee the family caregiver, answer health-related questions, and provide emotional support; conducting home visits about once per month; and passing a fixed percentage of the stipend (usually 50%–65%) on to the family caregiver. Among the handful of payment rates reported in an overview of the program by the American Council on Aging, payments to family members in 2026 are about $40–$70 per day. States reported structured family caregiving programs in the following home care waivers:

  • Adults ages 65 and older and those with physical disabilities in nine states (Connecticut, Georgia, Indiana, Louisiana, North Carolina, North Dakota, Ohio, Rhode Island, and South Dakota),
  • People with I/DD in Indiana and New Hampshire,
  • Medically fragile children in North Carolina,
  • People with traumatic brain and/or spinal cord injuries in Indiana, and
  • People with Alzheimer’s or dementia and related disorders in Missouri and Nevada. 

Nevada’s structured family caregiving program is new in 2026, but it represents a new service rather than replacing a program that pays providers on an hourly basis. The program is available under a new waiver that was approved in 2025 but did not launch until 2026, which the state attributed to shortages among case management providers.

Four additional states do not currently offer structured family caregiving but plan to add the benefit (Kansas for individuals with mental health conditions, and Maryland, Michigan, and Oklahoma for adults ages 65 and older and those with physical disabilities). Right now, those waivers in Kansas and Maryland do not offer any payments to family caregivers, so the structured family caregiving benefit will allow families to newly receive some compensation. One state (Massachusetts) offers structured family caregiving as a state plan benefit for adults in foster care.

What Other Types of Support Does Medicaid Home Care Provide for Family Caregivers?

All responding states provide support for family caregivers—who may be paid or unpaid—and most offer more than one type of support (Figure 5, Appendix Table 7). All responding states reported covering respite care, which provides short-term relief for caregivers, allowing them to rest, travel, attend appointments, or spend time with other family and friends. Other commonly covered benefits include caregiver training (40 states) and counseling or support groups (25 states). Delaware, Missouri, Nevada, and Rhode Island reported newly covering caregiver training in 2026; and Arizona is implementing a new program offering peer-to-peer family support for paid and unpaid family caregivers.

All Responding States Provide Supports for Family Caregivers Through Medicaid Home Care (Grouped column chart)

Respite care may be provided anywhere from a few hours to several weeks at a time. Medicare covers respite care only for people who are receiving hospice care, which is available only to people who are terminally ill and elect to receive comfort care instead of curative care for their illness. That makes Medicaid’s respite care the primary source of coverage for caregivers of people with Medicare and Medicaid. Respite care is offered most frequently under waivers for people with I/DD (44 states) and adults ages 65 and older and those with disabilities (43 states).

Daily respite care is offered by most states (44 states), followed by institutional respite care (43 states) (Figure 6, Appendix Table 8). Daily respite care is available under waivers for people with I/DD in 33 states and available in 28 states within waivers for adults ages 65 and older and those with physical disabilities. Thirty states provide institutional respite care within waivers for adults ages 65 and older and those with physical disabilities, and 26 provide it within waivers for people with I/DD. Weekly respite care is the least frequently offered (29 states total), and over half of states (27) report offering other types of respite care, such as hourly, monthly, or annual.

Among Waivers and Programs, States Are Most Likely to Offer Daily Respite Care (Grouped column chart)

This work was supported in part by Arnold Ventures. KFF maintains full editorial control over all of its policy analysis, polling, and journalism activities.

States' Policies to Allow Medicaid Home Care Payments to Spouses, Parents of Minor Children, and Other Legally Responsible Relatives for Caregiving (Table)
States' Policies to Allow Individuals to Self-Direct Medicaid Home Care by Waiver/Program (Table)
States' Policies to Allow Individuals Using Medicaid Home Care to Hire Independent Providers (Table)
States' Policies for Using a Fiscal Intermediary to Pay Providers (Table)
States' Policies to Allow Medicaid Home Care Payments to Spouses, Parents of Minor Children, and Other Legally Responsible Relatives as well as Family and Friends for Caregiving (Table)
States Offering the Structured Family Caregiver Program, Which Supports Unpaid Caregivers of Persons Who Are Using Medicaid Home Care, and Waivers the Program Is Offered Under (Table)
States’ Policies for Offering Different Types of Family Caregiving Supports (Table)
Types of Respite Care Offered by State and Home Care Program: Daily, Weekly, Institutional, and Other (Table)

Out-of-Pocket Costs for Insulin Among People with Medicare Decreased by Half Between 2020 and 2024

Authors: Juliette Cubanski, Meredith Freed, and Anthony Damico
Published: Nov 20, 2026

Addressing the cost of insulin has been at the forefront of policy discussions around prescription drug prices for several years, amid public concern about high drug prices and challenges for Americans in affording prescription drugs. The Inflation Reduction Act (IRA) of 2022, signed by President Biden, included several provisions related to prescription drug spending in Medicare, including a provision to cap Medicare beneficiaries’ monthly out-of-pocket costs for insulin to $35 beginning in 2023, including all insulin products covered under the Part D prescription drug benefit and under Part B. A separate voluntary, time-limited model (called the Part D Senior Savings Model), initiated under the first Trump administration, was in effect for some Medicare Part D enrollees starting in 2021, with participating Part D plans agreeing to cap monthly copays for selected insulin products to $35. This model was in effect through the end of 2023. Legislation to extend the $35 insulin copay cap to people with private insurance has been introduced by policymakers at the federal level but not enacted. Similar actions at the state level are also underway.

This analysis examines out-of-pocket costs for insulin among Medicare Part D enrollees between 2020 and 2024 to assess changes over time as these voluntary and mandatory insulin copay limits took effect. The analysis is based on Medicare Part D prescription drug event data and focuses on costs among enrollees without Part D Low-Income subsidies (LIS) who used any insulin product during this period, since enrollees who receive LIS face only nominal copays for their prescriptions. The implementation of these voluntary and mandatory measures to improve the affordability of insulin for Medicare Part D enrollees resulted in a substantial reduction in out-of-pocket spending by enrollees without low-income subsidies who used insulin, with out-of-pocket spending on insulin decreasing from $971 million to $506 million in the aggregate between 2020 and 2024 and from $54 to $25 for each insulin prescription over the same period.

Among Medicare Part D Enrollees Without Low-Income Subsidies, Total Out-of-Pocket Spending on Insulin Decreased from Nearly $1 Billion in 2020 to $0.5 Billion in 2024

For Part D enrollees without LIS, aggregate out-of-pocket spending on insulin decreased by 23% between 2020 and 2021, the first year of the temporary Part D Senior Savings Model, from $971 million to $745 million, and then decreased further to $677 million in 2022, the second year of the model (Figure 1). In 2023, the first year of the IRA’s mandatory $35 insulin copay cap, out-of-pocket spending decreased by an additional 23% to $514 million, followed by a modest decrease in 2024 to $506 million. Including Part D enrollees with LIS, aggregate out-of-pocket spending on insulin decreased from slightly over $1.0 billion in 2020 to $535 million in 2024.

Out-of-Pocket Spending on Insulin by Medicare Part D Enrollees Without Low-Income Subsidies Decreased From Nearly  Billion in 2020 to $.5 Billion in 2024 (Column Chart)

The number of Part D enrollees overall using insulin increased over these years from 3.3 million to 3.5 million, while the total number of insulin prescriptions filled (per 30-day supply) increased from 37.5 million to 38.8 million. Among Part D enrollees without LIS, the number of insulin users increased over these years from 1.7 million to 1.9 million, while the total number of insulin prescriptions filled (per 30-day supply) increased from 18.1 million to 20.4 million. While the number of insulin users and insulin prescriptions increased in the aggregate over this period, insulin use on a per capita basis was flat over these years (11 fills per user), suggesting that the aggregate increase is likely related to increased enrollment in Part D overall.

Out-of-Pocket Costs per Insulin Prescription Among Enrollees Without Low-Income Subsidies Decreased by Half (54%) Between 2020 and 2024, from $54 to $25

For Part D enrollees without LIS, out-of-pocket spending per insulin prescription decreased from $54 in 2020 to $40 in 2021, the first year of the temporary Part D Senior Savings Model, a 26% reduction (Figure 2). Out-of-pocket spending per insulin prescription decreased an additional 28%, from $36 in 2022 to $26 in 2023, the first year of the IRA’s mandatory $35 insulin copay cap, followed by a modest reduction to $25 in 2024.

Out-of-Pocket Spending Per Insulin Prescription by Medicare Part D Enrollees Without Low-Income Subsidies Decreased By Half From  to  Between 2020 and 2024 (Column Chart)

With enrollees filling 11 insulin prescriptions each year over this period, annual out-of-pocket spending on insulin among these same enrollees decreased at the same rate, a 54% reduction, from $572 to $265 between 2020 and 2024 (Figure 2).

Average Out-of-Pocket Costs for a 30-Day Supply of the Top 10 Most Commonly Used Insulin Products Available in Both 2020 and 2024 Decreased Over This Period

In 2020, Part D enrollees without LIS paid more than $35 for a 30-day supply of each of the 10 most commonly used insulin products, ranging from a high of $70 for Tresiba Flextouch U-200 down to $43 for Insulin Lispro Kwikpen U-100. By 2024, out-of-pocket costs for each product had fallen below $35 and ranged from a high of $29 for Basaglar Kwikpen U-100 down to $23 for Lantus Solostar (Figure 3).

Out-of-Pocket Costs by Medicare Part D Enrollees Without Low-Income Subsides for the Top 10 Most Commonly Used Insulin Products Available in Both 2020 and 2024 Decreased Over This Period (Table)

This work was supported in part by Arnold Ventures. KFF maintains full editorial control over all of its policy analysis, polling, and journalism activities.

Juliette Cubanski and Meredith Freed are with KFF. Anthony Damico is an independent consultant.

Exploring Insulin Cost-Sharing Caps for Patients with Private Coverage

Authors: Kaye Pestaina, Faiz Yasin, Michelle Long, Rayna Wallace, and Justin Lo
Published: Nov 20, 2026

Nearly 29 million adults in the U.S. have been diagnosed with diabetes, with 32% of them taking insulin to manage it. The cost of insulin has been a barrier to care for many Americans. A monthly cap on patient cost sharing is one approach aimed at reducing cost-related barriers for people using insulin. While caps do not directly address the underlying price of insulin, they may make patient costs more affordable and support consistent access to this medication. Since 2023, people with Medicare generally have a $35 monthly cap on the cost of insulin. A 2024 KFF poll found that 3 in 4 adults support expanding this cap beyond just those with Medicare. Public support for these protections is also notably bipartisan, with 84% of Democrats and 70% of Republicans in favor.

Applying a cost-sharing cap on insulin to private insurance coverage, including employer coverage, has been gaining momentum among policymakers. Since 2019, an increasing number of state laws have limited cost-sharing for insulin in state-regulated plans, and a federal insulin cost-sharing cap for consumers with private coverage has advanced in Congress this year. This Issue Brief explains the evolution of insulin cost-sharing caps in recent years, including existing state laws and their limitations, the proposed federal legislation, and key policy considerations when assessing whether this approach may improve insulin affordability for consumers.

Background

Insulin affordability has long concerned policymakers. Between 2007 and 2018, the list prices of some forms of insulin increased by more than 260%, according to one study. In Medicare Part D alone, aggregate patient out-of-pocket spending for insulin products quadrupled between 2007 and 2020, according to a KFF analysis.

Examinations have linked high insulin costs, in part, to increasing drug manufacturer list prices and certain contracting and other business practices by pharmacy benefit managers (PBMs). In 2019, the Senate Finance Committee began an investigation into rising insulin prices, culminating in a 2021 report examining the roles of the three major insulin manufacturers (Eli Lilly, Novo Nordisk, and Sanofi) and the major pharmacy benefit managers (CVS Caremark, Express Scripts, and Optum Rx) that administer pharmacy benefits for insurers and employers. The committee concluded that the three drug manufacturers “aggressively” raised the list price of their insulin products, often in lockstep with each other. The “list price” (also called the Wholesale Acquisition Cost (WAC)) is the starting price set by drug manufacturers, later reduced through various discounts and negotiations with PBMs.

The committee also stated that the three largest PBMs have significant marketing power to negotiate rebates with drug manufacturers. Rebates are discounts off the list price that PBMs negotiate with drug manufacturers in exchange for preferred placement of the drug on a health plan formulary. The committee determined that, “… the practice of offering rebates in the insulin therapeutic class appears to be contributing to both increasing insulin WAC prices and limited uptake of lower-priced products.” This, among other factors, the report concluded, can keep insulin out-of-pocket costs high for individual consumers partly because plan formularies often favor higher-cost insulins (with the highest rebates) while excluding or disadvantaging lower-priced insulins.

Other studies have highlighted insulin affordability issues for those who have to pay for it out of pocket at a high list price before meeting their deductible, when insurance begins to pay, as well as those whose cost sharing is pegged to a high list price (e.g., coinsurance). Additionally, privately insured patients typically pay for insulin based on a negotiated rate that does not reflect manufacturer rebates, which may reduce what a plan pays for the insulin but are not necessarily passed through to the patient.

In the years since these evaluations, federal efforts to lower insulin out-of-pocket costs have progressed, notably the passage of the Inflation Reduction Act of 2022 (IRA). Among other prescription drug cost reforms, the IRA established a cost-sharing cap for a month’s supply of any covered insulin for Medicare beneficiaries beginning in 2023. The law limits monthly copayments to the lesser of $35 or 25% of the negotiated price for the insulin in the Medicare Part D plan, or 25% of the price for the insulin negotiated if it is part of the Medicare price negotiation program. A KFF analysis found that out-of-pocket insulin costs for Medicare beneficiaries decreased by half between 2020 and 2024.

Although earlier versions of the IRA would have put the same cap on monthly cost sharing for those in private plans (e.g., employer-sponsored plans and on- and off-Marketplace individual market coverage), this was dropped from the IRA prior to passage. A Peterson-KFF Health System Tracker analysis of 2018 claims data found that a $35 cap would have financially benefited at least 1 in 5 enrollees in private insurance plans who use insulin.

While those with private coverage do not have the cost-sharing protection that Medicare Part D beneficiaries have, Internal Revenue Service (IRS) guidance has allowed those with health savings accounts (HSAs) to access certain preventive services before paying their annual deductible, including insulin and certain supplies (if implemented by their employer or other plan sponsor). Congress added this pre-deductible insulin provision, which is limited only to those with HSAs, in the Inflation Reduction Act. According to the 2026 KFF Employer Health Benefits Survey, 29% of covered workers are enrolled in HSA-qualified high-deductible plans.

Voluntary drug manufacturer price reductions starting in 2023 lower the cost of certain insulins. In March 2023, the three major insulin manufacturers announced that they would significantly cut the list price of certain insulins and expand their existing discount programs for those with private coverage, capping patient cost sharing for insulin at $35 per month at certain retail pharmacies. While the introduction of biosimilar and unbranded insulin also likely played a role in reducing costs, this voluntary manufacturer price reduction has largely been attributed to a change in how Medicaid rebates are calculated. Under the Medicaid Drug Rebate program, drug manufacturers give rebates to federal and state governments in exchange for coverage of their drug under the Medicaid program. The amount to be paid in rebates was limited under a formula in place since 2010. The American Rescue Plan Act of 2021 eliminated the limit on these rebates to Medicaid. This would have substantially increased what drug manufacturers pay to Medicaid in rebates for certain insulins if drug manufacturers did not reduce the price of insulin available to commercial payors.

Other federal action and state litigation aim to address insulin prices and costs. While congressional actions focused on reducing costs for prescription drugs broadly—including a PBM transparency and rebate reform law passed earlier this year and efforts to bring more lower-cost biosimilars to market—likely impact insulin costs, other activity focused specifically on insulin pricing includes:

Federal Trade Commission (FTC) action. The FTC filed an administrative complaint in September 2024 against the three largest PBMs (and their subsidiaries) alleging that they systematically prefer high-list-price insulin products with high rebates over lower-priced ones. According to the FTC, these PBMs artificially inflated prices, shifting costs to consumers and constituting an unfair act or practice and unfair method of competition under federal law. In 2026, the FTC settled with two of these PBMs (Express Scripts and CVS Caremark), which agreed to make specific changes to their prescription drug pricing and rebate practices by 2028, including providing broader access to existing PBM programs that cap enrollee out-of-pocket payments for insulin at a set dollar level, some as low as $25 for a month’s supply. PBMs also agreed to count cash payments made for medications using TrumpRx coupons toward a patient’s deductible and out-of-pocket maximum if certain legal and regulatory changes are made. It is not clear whether and how this will be implemented.

Separate state litigation. Some state attorneys general (AGs), cities, school districts, and other plaintiffs have sued the leading insulin manufacturers and PBMs, alleging anticompetitive and/or deceptive practices related to high insulin prices. State AGs in Republican-led and Democratic-led states have filed actions over the past three years, many of which have been consolidated with hundreds of other similar cases in a federal district court. These cases largely allege violations of state antitrust and consumer protection laws, seeking both to stop drug manufacturer and PBM practices that they allege inflate insulin prices, and to secure damages for affected consumers and employers. No major court decisions or settlement agreements have been issued yet in these cases.

Alternative pathways to lower-cost insulin are gaining momentum. New approaches to insulin production and distribution are opening new access points for patients. For instance, California recently began producing its own biosimilar insulin (glargine) through its CalRx program, allowing patients who use this specific type of insulin to purchase it at a lower cost, with or without insurance. PBMs and other third parties are also manufacturing private-label biosimilar insulins, but their long-term impacts on patient costs are unclear: with financial incentives to promote their own private-label drugs, PBMs are not inherently incentivized to pass on savings to insurers and their enrollees.

A growing direct-to-consumer sales market gives patients another avenue to purchase insulin at discounted prices, mostly on a cash-pay basis outside of insurance, from online pharmacies such as Amazon Pharmacy and certain drug manufacturers. Additionally, discount platforms like GoodRx and TrumpRx provide coupons that consumers can use to purchase medications from participating pharmacies. Certain consumers, such as those with low incomes, may find even lower costs from manufacturer-sponsored patient assistance programs and through other pathways.

State Insulin Cost-Sharing Caps

According to KFF analysis of state laws, as of October 2026, 29 states (nearly 60%) and the District of Columbia have enacted laws that cap cost sharing for insulin for privately insured patients, beginning with Colorado in 2019 (Figure 1). At least 11 states with relatively high rates of diabetes do not have laws capping insulin cost sharing. While state cost-sharing protections can provide a useful framework for developing federal policy, as discussed below, their reach is limited to a relatively small share of people with private health coverage. Separately, some states have eliminated cost sharing for insulin in certain types of ACA Marketplace plans and/or have implemented other programs to help uninsured and underinsured patients afford their insulin.

Cost-sharing Caps for Those with Private Insurance

Dollar Cap Amounts

The dollar amounts of insulin cost-sharing caps vary by state. While some states have lowered their caps since enacting their first laws, caps currently range from $0 in New York and Massachusetts (generic only) to $100 in Alabama, Colorado, Delaware, and Vermont for a 30-day supply (Figure 1). The most common cap amount for a 30-day supply is $35. About three-quarters of states with insulin cost-sharing caps currently limit out-of-pocket spending to $35 or less, while seven states have caps higher than $35. (One of these states, VA, will reduce its cost-sharing cap to $35 beginning January 2027.) Two states (OK and OR) also extend corresponding out-of-pocket caps for a 90-day supply of insulin. Links to current state laws are included in the map below.

Dollar Cap Structure

The structure of insulin cost-sharing caps is relevant for people who use multiple insulins each month. While caps in most states are structured as a separate amount for each prescription, at least four states (CO, DE, VT, and WV) currently have aggregate caps that apply to total out-of-pocket spending for all covered insulin products a patient may purchase in a month. (VA’s cap will change from separate to aggregate in 2027.) For example, under a $35 aggregate cost-sharing cap, a patient who uses two different types of insulin would pay no more than $35 per month, compared to no more than $70 per month under a separate per-prescription cap.

Drugs and Other Items Covered by Caps

Many state caps apply broadly to prescription drugs containing insulin used to treat diabetes, regardless of form (e.g., vial, pen, inhaled) or type (e.g., rapid-acting, short-acting, intermediate-acting, long-acting). Some states have additional requirements. For example, Connecticut’s cost-sharing cap also applies to noninsulin diabetes drugs (e.g., glucagon). Most caps apply only to the actual drug product itself, but five states (CT, DE, MN, ND, and WV) and DC also have separate out-of-pocket caps for diabetes-related medical supplies and equipment such as glucometers, testing strips, pens and syringes, and laboratory testing for diabetes-related markers, ranging from $25 (ND) to $100 (WV and DC) per monthly supply of covered items. (VA will institute a $35 cost-sharing cap for supplies beginning in 2027.)

Limitations of State Caps

According to KFF analysis of the 2024 Behavioral Risk Factor Surveillance System (BRFSS) data, 8% of privately insured adults have been diagnosed with diabetes, ranging from 4% in the District of Columbia to 12% in West Virginia (Figure 1). Although state cost-sharing caps generally apply to both the individual and group markets, in practice, only a small fraction of those individuals benefit from these laws. A key limitation of state insurance laws is that they generally don’t apply to most people with employer-sponsored coverage, the largest source of coverage for those under age 65. Federal law (the Employee Retirement Income Security Act of 1974, or ERISA) exempts self-funded health plans established by private employers (but not public employers) from most state insurance laws. In 2026, 7 in 10 (70%) workers with job-based coverage are enrolled in this type of plan. Put into perspective, this means only 3 in 10 (30%) workers with employer-sponsored insurance, plus the much smaller share of people with state-regulated individual coverage, such as ACA Marketplace plans, are reached by state cost-sharing caps. Absent a federal cost-sharing cap, which would extend to plans governed by ERISA, the scope and application of state cost-sharing protections will remain limited.

29 States and DC Have Cost-Sharing Caps on Insulin for Private Insurance (Choropleth map)

No Cost Sharing for Insulin in Some State ACA Marketplace Plans

In addition to the broadly applicable statutory cost-sharing caps described above, at least three state-based ACA Marketplaces have used their administrative authority to eliminate all cost sharing for specific chronic condition maintenance drugs, including insulin, for certain enrollees. For example, enrollees in specific Marketplace plan types or cost-sharing tiers in the District of Columbia and Maryland have $0 cost sharing for select insulins (and certain related supplies). Cost sharing was also eliminated for lower-income Marketplace enrollees in Massachusetts.

Out-of-pocket Insulin Caps for the Uninsured and Underinsured

According to KFF’s analysis of 2024 BRFSS data, 7% of uninsured adults have been diagnosed with diabetes. Uninsured individuals generally receive less health care than those with insurance. In 2024, 42% of uninsured adults under age 65 with diabetes delayed or avoided receiving needed care due to the cost, compared to 11% of those with insurance. At least three states—CO, ME (until 2027), and MN—have implemented separate affordability programs that cap insulin costs for uninsured, as well as certain underinsured patients.

Affordability Safety Net Programs

Laws in Minnesota and Maine require large insulin manufacturers to establish insulin patient assistance programs for uninsured and underinsured residents of those states with family income of 400% or less of the federal poverty level. Under these “continuing needs” programs, eligible patients receive a 90-day supply of insulin at no charge from the manufacturer for up to a year, though pharmacies may charge the patient a dispensing fee of up to $50 per fill. Colorado also has a continuing-needs insulin program for uninsured and underinsured individuals, but with some differences, including that eligibility is not limited to those with lower incomes and the optional dispensing fee is based on a 30-day supply.

Urgent Need Programs

Minnesota, Maine (until 2027), and Colorado require insulin manufacturers to establish “emergency” insulin programs that provide one 30-day supply of insulin per year to eligible uninsured and underinsured residents who have less than a 7-day supply of insulin readily available. While there is no charge for the insulin itself, pharmacies are permitted to charge the patient a dispensing fee of up to $35.

Proposed Federal Insulin Cost-Sharing Cap

Bipartisan federal legislation known as the Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act of 2026 would impose a national insulin cost-sharing cap for private insurance and establish a pilot program to assist the uninsured. Similar bills have been introduced in previous years, but this year’s was considered and approved by the Senate Health, Education, Labor and Pensions (HELP) Committee over the summer; a companion bill was subsequently introduced in the House. Whether Congress will try to advance this legislation in the remaining lame-duck session this year or start over with the new Congress next year is unknown. Key provisions of the INSULIN Act include:

A requirement for private plans to cover “selected insulin products.” Plans would be required to cover at least one insulin of each dosage form of each insulin type. Plans and insurers make the selection, so coverage of specific insulins would likely differ by plan. The requirement extends to all employer-sponsored health plans (insured and self-funded), including non-Federal governmental plans, as well as individual market plans (including Marketplace plans). The legislation does not apply to non-insulin diabetes medications or supplies.

A $35 cost-sharing cap for a 30-day supply of insulin across all private insurance coverage. The INSULIN Act would require plans to cap enrollee cost-sharing payments for the plan’s selected insulin products at $35 per 30-day supply, or 25% of the plan’s negotiated price, whichever is less. Plans are not required to apply this cap for insulins delivered by an out-of-network provider. While the legislation does not define “negotiated price,” it requires that the negotiated price is “net of all price concessions received by or on behalf of the plan or issuer,” including PBMs and third-party administrators. This likely means that the negotiated price must take into account all rebates received by these entities.

No deductibles would apply before cost sharing starts. Health plans would be prohibited from applying a deductible to their selected insulins. This would apply even to catastrophic plans available on ACA Marketplaces where, currently, enrollees must pay a high deductible ($10,600 for an individual or $21,200 for a family in 2026) before their coverage kicks in. The exemption from the deductible for the selected insulins cannot be treated as increasing the actuarial value of a qualified health plan.

Selected insulin would be treated as an essential health benefit. The legislation also states that the selected insulin product should be treated “as though such benefits were required to be provided” as an essential health benefit (EHB). Insurers in the individual and small group market are required to cover EHBs and count patient cost sharing for them toward the ACA’s required patient out-of-pocket maximum ($10,600 for an individual or $21,200 for a family in 2026).

Limits on prior authorization for selected insulins. The legislation would prohibit plans and insurers from imposing prior authorization requirements on the selected insulin products except as “clinically justified for safety reasons, to ensure reasonable quantity limits and as specified by the Secretary.” While this does not ban prior authorization, it might put new requirements on plans to justify why prior authorization is required for the plan’s selected insulins.

New pilot program for the uninsured. The bill would also create a temporary program to help address barriers for uninsured people using insulin. The 5-year, $100 million pilot program would be implemented across 10 states with high rates of uninsured people with diabetes. States would direct grant funds to assist in obtaining insulin and expanding access to on-site pharmacies at federally qualified health centers, provide additional support to community pharmacies where uninsured individuals obtain low-cost insulin, and assist low-income patients in accessing manufacturer drug discounts on insulin. The bill would also establish a separate $2 million national insulin resource center and hotline project to connect patients with outreach and assistance programs.

Changes to increase access to biosimilars. The INSULIN Act also proposes changes to Food and Drug Administration (FDA) approval processes to provide quicker access to new biosimilar medications. The FDA has approved a total of six insulin biosimilars since it implemented a new regulatory pathway to approval for biologic drugs in 2020.

Policy Considerations

Expanding out-of-pocket caps at the state level, or passing a federal out-of-pocket cap for insulin, could make insulin more affordable for consumers and provide some assurance that their out-of-pocket costs for insulin should not exceed a certain threshold. While the INSULIN Act of 2026 would fill the gaps in the current patchwork of state insulin cost-sharing caps and provide a federal floor of protections, it does not regulate the price of insulin or directly address the current dynamics of manufacturer rebates and formulary placement that may have led to high prices. Some considerations for policymakers include:

The extent to which a federal cap would substantially change what patients with private coverage pay for insulin. In recent years, some studies of state out-of-pocket caps on insulin showed only modest reductions in consumer out-of-pocket costs, possibly because many with private insurance already had relatively low cost sharing for some insulin types. A Department of Health and Human Services (HHS) analysis estimated that average out-of-pocket spending for a monthly supply of insulin was under $20 in 2025, which it attributed to a range of factors including manufacturer list price reductions and patient assistance programs, state cost-sharing caps, biosimilar competition, and pre-deductible coverage of insulin for those with health savings accounts. However, another recent analysis found that even though the share of insulin users with employer-sponsored coverage who spent over $35 out of pocket for a 30-day supply decreased from 2019 to 2023, about four in ten (41%) still spent over $35 per month in 2023, including more than two in ten (23%) who spent more than $50 per month. Although the 2023 claims data predate some of the more recent voluntary manufacturer price reductions and state-level insulin cost-sharing caps, some of these individuals could likely still benefit from the proposed federal cost-sharing cap.

Although direct-to-consumer (DTC) options offered by some manufacturers and online pharmacies may provide some insulin users with a less expensive alternative than the proposed $35 cost-sharing cap, federal law does not currently require cash payments made through these channels to count toward a private health plan’s deductible or out-of-pocket maximum. The INSULIN Act would not change this. Furthermore, it remains to be seen whether manufacturer-sponsored DTC options are an attempt to foreclose additional state and federal cost-sharing caps or whether they could affect the durability of voluntary price reductions.

How other federal actions could intersect with the proposed cost-sharing cap and impact insulin prices for privately insured and uninsured consumers. The inclusion of insulin on the Medicare drug price negotiation list, another federal law that will require PBMs to pass through all rebates to health plans sponsored by private employers, and new requirements on PBMs under FTC settlements are just some of the moving parts that could influence insulin pricing going forward. This shifting policy landscape operates alongside an evolving supply-side landscape. Beyond the scope of this issue brief are equally complex dynamics in FDA approval, manufacturing, and patient use of biosimilars and unbranded insulin, such as those developed under California’s new public program and by PBMs.

The impact of an out-of-pocket insulin cap on enrollees’ private insurance premiums and other out-of-pocket costs. Although the Congressional Budget Office (CBO) has not released a cost estimate for the INSULIN Act of 2026, insurers and employers could face increased plan costs, which they could pass on to enrollees through higher monthly premiums. In addition, to the extent that a federal insulin cost-sharing cap shifts more plan sponsor spending toward insulin, enrollees could see higher cost sharing for other items and services if plans seek to maintain their overall actuarial value (the average share of health care expenses for covered services that are paid by the plan, as opposed to those paid out-of-pocket by the enrollee). These dynamics could increase the overall financial burden on all consumers, including those taking other high-cost medications for diabetes (e.g., GLP-1s), cancer, or other illnesses that lack out-of-pocket caps.

Medicare Physician Payments: An Overview of Changes for 2027 and Broader Reform Efforts Under Discussion

Published: Nov 19, 2026

Overview

On November 4, 2026, the Centers for Medicare & Medicaid (CMS) finalized rulemaking changes to Medicare payments for physician services and other Part B services for 2027, including an average decrease in payment rates of -2.31% for most physicians relative to 2026. Most of this decrease comes from the expiration of funding passed by Congress under the 2025 federal budget reconciliation bill, which temporarily increased Medicare physician payment rates by +2.5% from January 1, 2026 through December 31, 2026. Qualifying participants in advanced alternative payment models, or A-APMs, who receive certain payment incentives each year, face a lower average decrease in payment rates of -1.83% relative to 2026.

The current system of Medicare physician payments was established under the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA), which implemented a schedule of fixed, annual statutory increases to the fee schedule conversion factor. This change was meant to replace the unpredictable fluctuations in payment caused by the prior payment system, which adjusted physician payment rates based on growth in the gross domestic product (GDP), with modest, predictable updates that do not vary based on underlying economic conditions. Beginning in 2026, most physicians receive a +0.25% statutory increase to Medicare payment rates each year, with a higher +0.75% increase available to qualifying A-APM participants. However, these payment rate increases can be offset or exceeded by negative budget neutrality adjustments, since the projected cost of all changes to the physician fee schedule must be budget neutral, which creates uncertainty from year to year. Further, because these scheduled payment updates are fixed in statute, they have not kept pace with inflation in medical practice costs, which has continued to grow in the years since MACRA was introduced.

According to CMS, budget neutrality adjustments for 2027 have been finalized at a modest -0.12%, but the expiration of the +2.5% payment rate increase provided by Congress for 2026 has led to the much larger -2.31% decrease in payments for most physicians in 2027. Congress has issued temporary funding to boost Medicare physician payments nearly every year since 2021, both to replace expiring congressional funding from the previous year and to offset the larger budget neutrality cuts required in some years. To date, Congress has not appropriated additional funds for 2027, though it is likely to be a topic as Congress considers ongoing government funding during the lame duck session.

Policymakers have also shown growing interest in proposals to reform Medicare’s approach to paying physicians under traditional Medicare, such as adjusting payment rates based on inflation in medical practice costs and relaxing budget neutrality requirements, raising the possibility that Congress may revisit broader Medicare physician payment reform proposals in the next legislative session. While physician payment could affect access to care for Medicare beneficiaries, physician participation in the Medicare program has been high and largely unchanged in recent years.

Context for CMS’s 2027 Physician Payment Rate Reduction

Medicare reimburses physicians and other clinicians based on the physician fee schedule, which uses a structured formula to assign payment rates for more than 10,000 health care services, such as office visits, diagnostic procedures, or surgical procedures, based on the relative time, effort, and practice costs required to furnish them. CMS adjusts these payment rates and other aspects of the Medicare physician payment system as part of its annual rulemaking process.

Under current law, the projected cost of all changes to the physician fee schedule must be budget neutral, meaning that the changes may not increase total Medicare spending by more than a nominal amount of $20 million in a given year. To meet this requirement, CMS balances annual adjustments to payment rates for new or existing services by offsetting the costs elsewhere in the fee schedule, often by adjusting all payment rates downward using a schedule-wide scaling factor known as the conversion factor.

This process has led to reductions in Medicare payments to physicians and other clinicians in several recent years, fueling concerns from physician groups and some policymakers that Medicare physician payment rates have not kept pace with inflation in medical practice costs. Core to these concerns for patients is the possibility that lower payment rates could lead some physicians to opt out of the Medicare program, potentially impacting beneficiaries’ access to physician services. While recent data suggests that virtually all non-pediatric physicians continue to accept Medicare payments, and beneficiary access to Medicare providers remains high, Congress has taken steps to mitigate the impact of the largest budget neutrality cuts, which have ranged upwards of -2.00% in several recent years, by passing legislation to provide short-term, temporary increases to the fee schedule conversion factor.

In contrast to budget neutrality cuts and other conversion factor adjustments required by statute or made by CMS through annual rulemaking, these temporary increases provided by Congress do not carry forward into future years. As a result, payment rates revert to their previous level whenever the funding expires, leading to a relative payment cut with respect to the previous year and renewing discussions around providing additional congressional support for the upcoming year. Since early 2021, Congress has provided a series of five temporary increases to Medicare physician payments (ranging from +1.25% to +3.75%) to offset payment cuts due in part to the expiration of the previous year’s short-term funding, even in cases where no new budget neutrality cut had been scheduled.

Broader Physician Payment Reform Efforts Under Consideration

Policymakers have shown growing interest in policies to reform Medicare physician payments in recent years, such as raising or modifying the $20 million budget neutrality threshold and regularly adjusting physician payment rates to reflect growth in the Medicare Economic Index (MEI), a measure of medical practice cost inflation maintained by CMS. In 2025, the Medicare Payment Advisory Commission (MedPAC) recommended that CMS replace MACRA’s current schedule of physician payment rate updates with annual updates tied to the MEI. However, in 2026, MedPAC issued a narrower recommendation for a single, permanent increase of +0.5% above current law, with no underlying change to current statute.

On September 15, 2026, the House Energy and Commerce Subcommittee on Health held a legislative hearing in which it considered more than a dozen bills related to Medicare provider payments and other issues, including four bills that proposed physician payment changes such as budget neutrality reform and inflation-based updates to physician payment rates. Among the bills considered was the bipartisan Patients First Act of 2026, which would raise the budget neutrality threshold from $20 million to $57.64 million in 2028, with additional increases based on cumulative MEI growth every five years thereafter, and would prohibit budget neutrality cuts above -2.5% in a given year. Additionally, the bill would replace MACRA’s schedule of physician payment rate updates with annual adjustments based on the projected increase in the MEI minus one percentage point for most physicians beginning in 2027 (with an additional +0.5% increase each year for qualifying A-APM physicians), similar to the updates recommended by MedPAC in 2025, among other reforms.

The Patients First Act of 2026, which has attracted the support of physician groups and state medical associations, shares several provisions with another bill, the Provider Reimbursement Stability Act, which passed the House Ways and Means Committee in May 2026, and both bills have upwards of 60 bipartisan cosponsors. The Congressional Budget Office (CBO) has not yet provided a cost estimate of the Patients First Act, but CBO has estimated that similar budget neutrality provisions in the Provider Reimbursement Stability Act would increase federal spending by just under $5 billion from 2026-2036.

Other provisions in the Patients First Act, such as the annual inflation-based adjustment to physician payment rates, have not been scored, but would likely require a significantly larger increase in federal spending. CBO estimated that a draft provision for annual adjustments to physician payment rates based on a smaller share of projected MEI growth (75% in the first year and 10% in all subsequent years), which was considered for inclusion in the 2025 federal budget reconciliation bill, would have increased federal spending by roughly $8.9 billion from 2025-2034. By way of comparison, the final provision to increase physician payments by 2.5% for the 2026 calendar year was estimated to increase federal spending by roughly $1.9 billion over the same period.

Whether Congress will take action to forestall the physician payment cut for 2027 during the lame duck session or defer action until the new congressional session is unknown. While the new Congress will usher in many new members, including some physicians, broader interest in Medicare physician payment reform efforts is likely to continue.

This work was supported in part by Arnold Ventures. KFF maintains full editorial control over all of its policy analysis, polling, and journalism activities.

News Release

About 3 in 10 Adults Have Provided Unpaid Care to a Friend or Family Member in the Past Year, Including Higher Shares of Women and People Ages 50 to 64 

Many Caregivers, Particularly Those Who Spend Longer Hours Caregiving, Report a Toll on Their Physical Health, Mental Health, and Finances 

Published: Nov 19, 2026

About 3 in 10 adults (29%) in the U.S. say they have provided unpaid care to a friend or family member who needs assistance due to aging, disability, or a chronic condition in the past 12 months, according to a KFF survey released today.

The KFF Survey of Health Access and Caregiving finds the median amount of time that such caregivers provide unpaid assistance is five hours per week, though the number of hours varies widely. Nearly half (45%) of unpaid caregivers (or 13% of all adults in the U.S.) spend four hours or less per week on these tasks, while about a quarter (23%; 7% of all adults) say they spend more than 15 hours a week.

The survey finds that unpaid caregivers are comprised disproportionately of women (57% are women, 42% are men). Unpaid caregivers also tend to be older than the adult population who do not provide unpaid caregiving (53% of caregivers are ages 50+ compared to 44% of non-caregivers). One-quarter (26%) of unpaid caregivers are parents or guardians of a child under 18 living in their household, and many unpaid caregivers (44%) say they are employed full-time, illustrating how many unpaid caregivers must juggle multiple responsibilities.

Substantial shares of unpaid caregivers say the work they do takes a toll on their own health and finances, particularly those who devote many hours to caregiving each week. Two-thirds (66%) of unpaid caregivers say they have experienced stress or worry related to their caregiving duties. At least a quarter say they have experienced worsening of their own mental (35%) or physical (29%) health or say they have experienced financial strain such as losing a job or having to work reduced hours (25%). The share reporting financial strain is highest among those who work part-time (41%) or are unemployed (34%). 

About eight in ten caregivers (81%) who spend over 15 hours weekly providing care say they have experienced stress or worry as a result, about half each say they have experienced a worsening of their own mental health (51%) or physical health (47%), and four in ten (41%) have experienced financial strain. Across all measures, these shares are substantially higher compared to those who spend fewer hours caregiving each week. Women caregivers are also somewhat more likely than men to report stress or worry and a worsening of their own mental or physical health due to caregiving duties.

Unpaid caregivers provide an array of essential assistance to the person they care for. Most commonly, these tasks include “housekeeping, grocery shopping, or preparing meals” (70% of all caregivers, including 72% of women and 66% of men). About half (51%) of unpaid caregivers say they manage an individual’s medical care, such as helping manage medications or transportation to medical appointments. Smaller, though still sizeable, shares report managing their finances (37%), making decisions about medical care like choosing a provider (30%), and providing physical care including helping them bathe or dress (26%).

Designed and analyzed by KFF public opinion researchers, KFF’s Survey of Health Access and Caregiving was conducted in English and in Spanish May 4 – 26, 2026, online and by telephone among a large, nationally representative sample of 25,873 adults, including 8,209 who say they have provided unpaid care to a friend or family member who needs assistance due to aging, disability, or a chronic health-related issue in the past 12 months. The margin of sampling error is plus or minus one percentage point for the full sample and plus or minus two percentage points for unpaid caregivers. For results based on other subgroups, the margin of sampling error may be higher.

Poll Finding

Experiences of Unpaid Caregivers in the U.S.

Published: Nov 19, 2026

Many people require assistance with everyday self-care due to chronic health conditions, disability, or aging. Informal caregivers, often family members, are unpaid and provide a wide range of assistance and help people live independently. Formal, paid caregiving, such as nursing home and home care, is typically very expensive, not covered by health insurance, and financially out of reach for many people. Therefore, informal caregivers often step in to fill this gap. This Poll Finding draws on data from the KFF Survey of Health Access and Caregiving to examine the experiences of unpaid caregivers in the United States, including the types of assistance they provide, which demographic groups spend the most time doing this work, and the toll that caregiving can have on the caregivers themselves.

Key Takeaways

  • About three in ten (29%) adults in the U.S. say they have provided unpaid care to a friend or family member who needs assistance due to aging, a disability, or a chronic health-related issue in the past 12 months. While the amount of time spent providing this type of assistance varies greatly, 5 hours per week is the median amount of time unpaid caregivers spend on caregiving tasks, with about a quarter of caregivers (7% of all adults) spending more than 15 hours a week on these tasks.
  • Many adults, regardless of age, income, race or ethnicity, and partisanship, provide caregiving assistance to a friend or family member, but women and those ages 50 to 64 are somewhat more likely than their counterparts to report engaging in these tasks. Across age and racial and ethnic groups, women are somewhat more likely than men to report being unpaid caregivers. Women also spend more time providing care, with one in four women caregivers (8% of all women ages 18 and over) spending more than 15 hours weekly on caregiving duties.
  • One-quarter (26%) of unpaid caregivers are parents or guardians of a child under 18 living in their household. Among caregivers under 50 years old, nearly half (45%) say they are parents or guardians of a child under 18.
  • Many caregivers say the work they do takes a toll on their own health and finances, including sizeable shares of caregivers who are actively managing their own health conditions, those who are also employed part-time, and those providing care for many hours per week. For example, about half of caregivers who spend over 15 hours weekly providing care, and four in ten who are managing three or more health conditions of their own, say their own physical or mental health got worse because of their caregiving duties.
  • Unpaid caregivers provide an array of essential assistance to the person they care for. Most commonly, these tasks include “housekeeping, grocery shopping, or preparing meals” (70%) and managing medical care (51%). Women caregivers are more likely to provide three or more types of assistance asked about in this survey compared to men (40% vs. 32%), rising to three-quarters of women caregivers who spend over 15 hours weekly on caregiving duties.

Unpaid Caregiving in the U.S.

Who Are Unpaid Caregivers?

About three in ten (29%) adults in the U.S. say they have provided unpaid care or assistance to a friend or family member who needs assistance due to aging, a disability, or a chronic health-related issue in the past 12 months.

The KFF Survey of Health Access and Caregiving finds unpaid caregivers (n=8,209) are comprised disproportionately of women (57% are women, 42% are men) and skew older than the adult population who do not provide unpaid caregiving (53% of caregivers are ages 50+ compared to 44% of non-caregivers). Unpaid caregivers reflect the racial diversity of the country as 63% of unpaid caregivers are White, 15% are Hispanic, 12% are Black, and 5% are Asian or Pacific Islander.1

Many unpaid caregivers (44%) report being employed full-time, though about four in ten say they are not employed at all, including 21% who are retired. One-quarter (26%) are parents or guardians of a child under 18 living in their household. Among caregivers under 50 years old, nearly half (45%) say they are parents or guardians of children under 18. One in six (16%) unpaid caregivers are parents or guardians to children under the age of 18 and are employed full-time, balancing multiple responsibilities along with providing caregiving assistance.

In addition to family demands, many unpaid caregivers are also actively managing their own health challenges, with three in ten saying they have been treated or have taken medication for 3 or more health conditions from a list of 18 conditions in the past 12 months2 (see here for a full KFF analysis on U.S. adults with multiple or complex health conditions).

See Appendix, Table 2 for a more detailed analysis of the demographic characteristics of unpaid caregivers in the U.S.

How Many Adults in the U.S. Are Unpaid Caregivers?

About three in ten (29%) adults in the U.S. provide unpaid care or assistance to a friend or family member, including a somewhat larger share of women (32%) compared to men (26%), and larger shares of adults ages 50 to 64 (36%) compared to younger and older age groups. Three in ten White adults (30%) and Black adults (29%) report engaging in unpaid caregiving over the past year, slightly higher than the shares among Hispanic (26%) and Asian or Pacific Islander adults (25%).

Gender plays a role in caregiving across most demographic groups, with somewhat larger shares of women than men reporting they are caregivers.3 For example, four in ten women between the ages of 50 to 64 say they have provided unpaid care or assistance to a friend or family member in the past 12 months, compared to 32% of men in the same age group. Similarly, about one-third of White women (33%) and Black women (32%) say they are unpaid caregivers, compared to somewhat smaller shares of White men (28%) and Black men (26%). Mothers of children under age 18 are also slightly more likely to be unpaid caregivers than fathers (30% vs. 27%).

Across most employment statuses (employed full-time, part-time, and retirees) and among those with household incomes over $40,000, women are somewhat more likely to be caregivers than their male counterparts, though among unemployed adults and those with annual incomes less than $40,000, similar shares are caregivers across gender.

Split bar chart showing population prevalence of unpaid caregiving among total adults, total women, and total men across specific demographics.

How Much Time Adults Spend Providing Unpaid Care

Five hours per week is the median amount of time unpaid caregivers spend providing assistance to a friend or family member. Yet, the experience varies widely with nearly half (45%) of unpaid caregivers (13% of total adults) spending 4 hours or less per week on these tasks, while about a quarter (23%; 7% of total adults) say they spend more than 15 hours a week. Women are somewhat more likely than men to spend over 15 hours weekly as unpaid caregivers (8% of all women vs. 5% of all men), rising to about one in ten among women ages 50 to 64 (11%) and among Black women (10%). See Appendix, Table 3 for more analysis on time spent caregiving among women and men across several demographics.

Perhaps reflecting the high costs of paying for caregiving or that they may have cut back on employment to provide caregiving assistance, lower-income adults spend more time caregiving weekly compared to higher-income adults, with one in ten of those with household incomes below $40,000 caregiving for over 15 hours compared to 4% of those with incomes over $100,000. Additionally, while those who work full-time report spending fewer hours caregiving than adults working part-time and unemployed adults, 5% of full-time workers still report spending over 15 hours a week as unpaid caregivers.

Stacked bar chart showing amount of time unpaid caregivers spend weekly on caregiving tasks. Results reported among total adults.

The Toll of Unpaid Caregiving

The survey shows the physical, mental, and financial toll on unpaid caregivers. Two-thirds (66%) of unpaid caregivers say they have experienced stress or worry related to their caregiving duties. In addition, at least a quarter say they have experienced worsening of their own mental (35%) or physical (29%) health or say they have experienced financial strain such as losing a job or having to work reduced hours (25%). Previous KFF focus groups of unpaid family caregivers found some participants emphasized reducing their number of working hours because of caregiving and difficulty balancing their own health care needs.

Women who are unpaid caregivers are somewhat more likely to report stress or worry related to caregiving (68% vs. 62% of men), as well as a worsening of their mental (38%) and physical (32%) health compared to men (29% and 26%, respectively).

Split bar chart showing percent of unpaid caregivers who have experienced specific negative impacts due to providing others with support. Results shown by total caregivers and caregivers by gender.

Many unpaid caregivers also report either full-time (44%) or part-time (16%) employment in addition to their caregiving duties, while a smaller share is either retired (21%) or unemployed (19%). The share reporting negative financial impacts due to caregiving is highest among those who are working part-time (41%) and those who are unemployed (34%), suggesting at least some of these caregivers may have had to switch from full-time to part-time work or have stopped working altogether because of caregiving duties. This is more common among men employed part-time compared to women (49% vs. 37%), while unemployed caregivers report financial strain at similar rates across gender. It’s also notable that among caregivers who are working full-time or are retired, women are more likely than men to report worsening of their own mental and physical health due to providing care.

Split bar chart showing percent of unpaid caregivers who have experienced specific negative impacts as a result of caregiving. Results shown by employment status among total caregivers and caregivers by gender.

The KFF Survey of Health Access and Caregiving also finds the more time unpaid caregivers spend weekly on providing assistance to friends and family, the greater the financial, physical, and mental toll they experience. About eight in ten caregivers (81%) who spend over 15 hours weekly providing care say they have experienced stress or worry as a result, about half each say they have experienced a worsening of their own mental health (51%) or physical health (47%), and four in ten (41%) have experienced financial strain. Across all measures, these shares are substantially higher compared to those who spend fewer hours caregiving each week.

Stacked bar chart showing percent of unpaid caregivers who have experienced specific negative impacts as a result of caregiving. Results shown by time spent caregiving weekly.

Experiences of Unpaid Caregivers Who Are Managing Their Own Health Conditions

Some unpaid caregivers are managing their own health conditions alongside providing health assistance for others, including three in ten who say they are dealing with multiple health conditions—defined as those who have been treated or taken medication for 3 or more health conditions from a list of 18 conditions in the past year. Given the mental and emotional strain that can often accompany caregiving, it’s also notable that 15% of caregivers report receiving treatment for a mental health condition in the past year.

Notably, a slightly larger share of women caregivers report dealing with these health challenges compared to their male counterparts, with more women caregivers managing three or more of their own health conditions (33% vs. 27% of men caregivers) or receiving treatment for a mental health condition (17% vs 12% of men caregivers).

Stacked bar chart showing number of active conditions and those who have been treated for a mental health condition among caregivers. Results shown among total caregivers and caregivers by gender.

Many unpaid caregivers who have their own health concerns report a worsening of their own physical or mental health due to providing care for others. For example, half (53%) of caregivers who are managing three or more of their own health conditions report a worsening of their own health because of their caregiving duties, including 41% who say their mental health got worse and the same share who report a worsening of their physical health. Among unpaid caregivers who are in active treatment for a mental health condition, about two-thirds (64%) say their mental health got worse as a result of their caregiving duties and 44% report a worsening of their physical health.

Stacked bar chart showing percent of unpaid caregivers who say they have experienced a worsening of their mental health, physical health, or either of the two due to caregiving. Results shown by number of active conditions of the caregiver and whether they were treated for a mental health condition.

Types of Assistance Unpaid Caregivers Provide

Unpaid caregivers provide an array of essential assistance to the people they care for. Most commonly, these tasks include “housekeeping, grocery shopping, or preparing meals” (70% of all caregivers, including 72% of women and 66% of men). About half (51%) of unpaid caregivers say they manage an individual’s medical care, such as helping manage medications or transportation to medical appointments. Smaller, though still sizeable, shares report managing their finances (37%), making decisions about medical care (30%), and providing physical care including helping them bathe or dress (26%).

Stacked bar chart showing percent of unpaid caregivers who provide specific types of assistance. Results shown by total caregivers and caregivers by gender.

Younger caregivers (those between ages 18 to 29) are slightly less likely than older caregivers (ages 30 and older) to report making financial and medical choices for the friend or family member they assist. About two in ten of this younger cohort say they make decisions about medical care, like choosing a provider, compared to at least three in ten older caregivers, and they are also less likely to say they manage their medical care or finances. Instead, caregivers under 30 report higher incidence of providing essential daily tasks, such as “housekeeping, grocery shopping, or meal preparation” (77%) or physical care (31%), than their older counterparts.

In contrast, the oldest group of unpaid caregivers—ages 65 and older—are less likely to say they are involved in more physically demanding caregiving tasks such as housekeeping, grocery shopping, or meal preparation (59%) and physical care (21%) than their younger counterparts. However, among caregivers ages 65 and older, women are somewhat more likely than men to report providing “housekeeping, grocery shopping, or meal preparation” (62% vs. 55%) and physical care (23% vs. 19%).

Stacked bar chart showing percent of unpaid caregivers who provide specific types of assistance. Results shown by age of caregivers.

The types of assistance that unpaid caregivers provide also varies somewhat by household income. For example, unpaid caregivers who earn less than $40,000 annually are more likely than their higher earning counterparts to provide more physically demanding tasks such as physical care (31%) or “housekeeping, grocery shopping, and meal preparation” (75%). In contrast, higher-earning unpaid caregivers report higher rates of managing medical care and finances, as well as making decisions about medical care like choosing a provider for the person they are assisting.

Stacked bar chart showing percent of unpaid caregivers who provide specific types of assistance. Results shown by household income of caregivers.

Notably, many unpaid caregivers provide multiple types of assistance to their friends or family members. Nearly four in ten (37%) say they provide at least three types of care asked about in this survey. Women caregivers are more likely to provide three or more types of care compared to men (40% vs. 32%), rising to three-quarters (76%) among women who spend over 15 hours a week caregiving.

The KFF Survey of Health Access and Caregiving was a series of questions designed and implemented by KFF with the SSRS Opinion Panel Mega-Omnibus. The survey was conducted May 4 – May 26, 2026, online and by telephone among a nationally representative sample of 25,873 U.S. adults in English (n=25,422) and in Spanish (n=451).

The SSRS Opinion Panel is a nationally representative probability-based panel where panel members are recruited randomly in one of two ways: (a) Through invitations mailed to respondents randomly sampled from an Address-Based Sample (ABS) through the U.S. Postal Service’s Computerized Delivery Sequence (CDS); (b) recruited via random digit dial (RDD) telephone sample of cell phone numbers connected to a prepaid cell phone. Both samples were provided by Marketing Systems Group (MSG). The combined sample was reached either online (n=24,875) or over the phone (n=998) based on the panelist’s stated preference. For the online panel component, invitations were sent to panel members by email followed by up to four reminder emails and up to two reminder text messages (if consented to receive SMS).

The questions designed by KFF were included as part of a multi-stakeholder effort designed to survey all individuals currently empaneled in the SSRS Opinion Panel, with each organization paying for and having independent editorial control over its survey questions.  Substantive questions from other outside stakeholders are redacted in this report. The SSRS survey team designed the questionnaire in order to minimize potential bias from question ordering. For more information, please contact SSRS.

Respondents who completed on the web received a $5 electronic gift card incentive (some harder-to-reach groups received a $10 electronic gift card). Respondents who completed the survey on the phone received $10 via a physical check in the mail. In order to ensure data quality, cases were removed if they failed two or more quality checks: (1) attention check questions in the online version of the questionnaire, (2) had over 10% item non-response, or (3) had a length of less than 30% of the mean length by mode. Based on this criterion, 69 cases were removed.

Data were weighted to represent adults 18+ in the United States. The Panel-wide base weight adjusts for the SSRS Opinion Panel recruitment and retention process. Because all current panelists (except 2026 recruits) were invited to participate and no further sampling was performed, no further adjustments to the Panel-wide base weight were necessary before applying it to the survey data.

With the Panel-wide base weight applied, the survey-data were weighted to match the sample’s demographic profile to the same target population parameters used in the calibration of the entire SSRS Opinion Panel. The demographic variables included in weighting for the general population sample are gender, age, race/ethnicity, and education (including interactions between these categories), as well as region, civic engagement, density, frequency of internet use, voter registration, political party identification, religion, household makeup, and home ownership. Final calibrated weights are trimmed at the 2nd and 98th percentiles to prevent individual interviews from having too much influence.

The margin of sampling error including the design effect for the full sample is plus or minus 1 percentage points. Numbers of respondents and margins of sampling error for key subgroups are shown in the table below. For results based on other subgroups, the margin of sampling error may be higher. Sample sizes and margins of sampling error for other subgroups are available on request. Sampling error is only one of many potential sources of error and there may be other unmeasured error in this or any other public opinion poll. KFF public opinion and survey research is a charter member of the Transparency Initiative of the American Association for Public Opinion Research.

GroupN (unweighted)M.O.S.E.
Total adults25,873±1 percentage point
   
Unpaid Caregivers8,209± 2 percentage points
Women caregivers5,204± 2 percentage points
Men caregivers2,902± 3 percentage points
   
Caregivers by Age  
18-29505± 6 percentage points
30-493,221± 2 percentage points
50-642,448± 3 percentage points
65+2,035± 3 percentage points
   
Caregivers by Hours Spent Providing Care  
0-4 hours3,852± 2 percentage points
5-15 hours2,546± 3 percentage points
16+ hours1,771± 3 percentage points

Table 1. Prevalence of Unpaid Caregivers by Gender Across Studies

Estimates of the population prevalence of unpaid caregivers differ somewhat based on the population surveyed and the question wording used to define caregiving. The table below includes estimates of caregiving overall and by gender from some recent studies.

StudyQuestion Wording or DefinitionPopulation Prevalence of Unpaid CaregivingPopulation Surveyed
KFF Survey of Health Access and Caregiving (May 4-26, 2026)At any time in the past 12 months have you provided unpaid care or assistance to a friend or family member who needs assistance due to aging, a disability, or a chronic health-related issue? 

By care or assistance, we are referring to providing help with activities (like bathing/dressing, grocery shopping, housekeeping, meal preparation, providing transportation to medical appointments, managing medications, help with bill-paying or managing their finances, arranging for outside services, etc.) for someone who needs assistance due to aging, a chronic condition, or other health issues.
29% of total population; 32% of women; 26% of menU.S. adults ages 18+
Caregiving in the US 2025, National Alliance for Caregiving and AARP (August 6-October 14, 2024)Family caregiver: Someone who has provided paid or unpaid care to a relative or friend 18 years or older to help them take care of themselves, or unpaid care to any child under 18 because of a medical, behavioral, or other condition or disability, in the last 12 months.24% of total population; 29% of women; 19% of men4U.S. adults ages 18+
American Time Use Survey, Bureau of Labor Statistics (2023-2024 averages)Eldercare provider: Someone who has provided unpaid care or assistance more than one time in the 3-4 months prior to the interview day to a person who needed help because of a condition related to aging. 

Estimates are restricted to eldercare providers caring for at least one person aged 65 or older.
14% of total population; 15% of women; 13% of menU.S. individuals ages 15+
National Poll on Healthy Aging, University of Michigan (February 22-March 12, 2024)In the past year, have you provided regular care or assistance to a family member or friend (adult or child) who has a health problem or disability?

Data shown are those who said “Yes, to someone who lives with me” or “Yes, to someone who does not live with me”
27% of total population; 32% of women; 22% of menU.S. adults ages 50+

Table 2. Demographic Profile of Unpaid Caregivers in the U.S.

Appendix table showing the demographic profile of caregivers by total caregivers and caregivers by gender. Profile also shown of non-caregivers.
Demographic Profile of Unpaid Caregivers in the U.S. (Table)

Table 3. Time Spent Providing Unpaid Care Weekly Among Total U.S. Adults

Average Hours Spent Providing Unpaid Caregiving Per Week Among U.S. Adults (Table)
Average Hours Spent Providing Unpaid Caregiving Per Week Among U.S. Adults (Table)
  1. 4% of unpaid caregivers identify as some other race (non-Hispanic) or multiple race (non-Hispanic). Persons of Hispanic origin may be of any race; other racial groups are non-Hispanic. The sample includes only English-speaking Asian adults and, therefore, may not be representative of the overall Asian adult population. ↩︎
  2. Number of active health conditions based on treatment in the past year for the following list: allergies, arthritis, back pain, cancer, cardiovascular disease, diabetes, hypertension, high cholesterol, lung disease, mental health condition, migraines, obesity, sinusitis, sleep disorder, thyroid problems, Parkinson’s disease, kidney disease, substance use disorder. ↩︎
  3. Other estimates of the population prevalence of unpaid caregivers across gender can be found in Table 1 of this report’s Appendix. ↩︎
  4. These estimates include family caregivers who provided unpaid care, paid care, or a combination of both, though AARP estimates only 1.9 million of 59 million caregivers are solely paid family caregivers. ↩︎

Senate Committee on Appropriations Releases FY 2027 Department of State, Foreign Operations, and Related Programs (SFOPs) and Labor, Health and Human Services, Education, and Related Agencies (Labor HHS) Appropriations Bills & Accompanying Reports

Published: Nov 18, 2026

The Senate Appropriations Committee released FY 2027 appropriations bills and accompanying reports for State, Foreign Operations, and Related Programs (SFOPs) — also referred to as National Security, Department of State and Related Programs [NSRP] in the FY 2026 final and FY 2027 House appropriations bills– as well as Labor, Health and Human Services, Education, and Related Agencies (LHHS) on November 16, 2026. These bills provide funding for the bulk of U.S. global health activities and include policy provisions that either impact or provide direction on global health funding as follows:

SFOPs: The SFOPs bill and explanatory statement include the following funding amounts and policy provisions for U.S. global health programs at the State Department.

  • Funding: Funding for global health programs at the State Department through the Global Health Programs (GHP) account totals $9.7 billion, an increase of $283 million (3%) compared to the FY26 level ($9.4 billion) and $815 million (9%) compared to the House 2027 appropriations bill ($8.8 billion).[i] The entire increase compared to FY26 is due to an increase in funding for the Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund); all other areas remained flat compared to FY26. See Table 1 for more details on FY 2026 Final, FY 2027 Request, and FY 2027 House funding levels.
  • Policy Provisions:
    • Funding Directives: The bill (sec 7019) specifically states that funding “shall be made available at not less than the amounts specifically designated in the respective tables included in the explanatory statement.” (While funding for bilateral HIV and the U.S. contribution to the Global Fund is specified in the bill, funding for most global health program areas is specified in a table in the explanatory statement.)
    • Global Fund: The explanatory statement accompanying the FY 2027 Senate bill states that the Global Fund amount is for the second installment of the eighth replenishment, “which are in addition to funds used to leverage the Global Fund’s Pooled Procurement Mechanism platform for commodities procurement to support U.S. bilateral MOUs.” The explanatory statement further states that funds “shall be” contributed on a quarterly basis and directs the Secretary of State use funds appropriated in prior acts to fulfill the U.S. commitment to the seventh replenishment.
    • Gavi, the Vaccine Alliance (Gavi): The explanatory statement states that the Gavi amount is for Gavi’s next strategic cycle.
    • Bridge Funding and Transitions: The explanatory statement directs the Secretary of State to consult with congressional committees on bridge funding, the transition of PEPFAR programs to countries, and to ensure that U.S. and local personnel are “maintained in partner countries to support oversight, coordination, and technical assistance.”
    • Funding Availability Timeframe: The bill (under Title III, Global Health Programs) specifies that PEPFAR funding (bilateral HIV and the contribution to the Global Fund) is available for five years. Funding for all other program areas is provided for two years, except for funding for Gavi and the Coalition for Epidemic Preparedness Innovations (CEPI), which is provided for one year.
    • Government-to-Government (G2G) Funding: The bill (sec 7031) details specific requirements that must be fulfilled before providing direct government-to-government assistance. For example, one requirement is for the recipient to have adopted “competitive procurement policies and systems” and another is for the recipient to take “demonstrable steps to publicly disclose on an annual basis its national budget, to include income and expenditures.”
    • Centers for Disease Control and Prevention (CDC) Transfers: The bill (sec 7058) states that PEPFAR funding “shall be transferred” to the CDC “in the amounts and manner similar to prior fiscal years,” but that this funding may be reduced “if offset by other sources of funding to the CDC in the implementation of the America First Global Health Strategy memoranda of understanding.”
    • Reports & Briefings/Consultations: The bill and accompanying explanatory statement require quarterly updates detailing the status of apportionment, allocation, obligation, and disbursement of funds as well as reports and/or briefings/consultations on Ebola; the Innovation Fund; President’s Malaria Initiative (PMI) transition; maternal and child health (MCH); medicine supply chain security; neglected tropical diseases (NTD) funding status; nutrition-specific output indicators; tuberculosis (TB) product development; global health programs staffing; frontline health workers; etc.

LHHS:

  • Funding: The LHHS bill and explanatory statement include funding for global health programs at the Centers for Disease Control and Prevention (CDC) as well as for global health research activities at the National Institutes of Health (NIH). Funding for global health programs at CDC was flat compared to 2026 and FY 2027 House levels.  Other than funding for the Fogarty International Center at NIH, which was flat, other funding for global health research at NIH is not yet known and will be determined at the agency level. See Table 2 for details on specific program areas and FY 2026 Final, FY 2027 Request, and FY 2027 House funding levels.
  • Policy Provisions:
    • Funding Directives: The bill (sec 236) states that funding “shall be for the budget activities, and in the amounts specified in the table under each such heading in the explanatory statement accompanying this Act.”
    • Coordination with the State Department’s Bureau of Global Health Security and Diplomacy (GHSD): The explanatory statement directs the CDC to continue coordination with State GHSD on PEPFAR, TB, President’s Malaria Initiative (PMI), and NTDs.

See the tables below for additional details on global health funding. See other budget summaries and the KFF budget tracker for details on historical annual appropriations for global health programs.

KFF Analysis of Global Health Funding in the FY 2027 Senate SFOPs Appropriations Bill & Explanatory Statement (Table)
KFF Analysis of Global Health Funding in the FY 2027 Senate Labor, Health and Human Services, Education, and Related Agencies (Labor HHS) Appropriations Bill & Accompanying Report (Table)

[i] The FY27 House bill and accompanying explanatory statement provide $8.8 billion to the GHP account. While the explanatory statement provides specific amounts for HIV/AIDS, Global Fund, TB, malaria, MCH, nutrition, the vulnerable children program, and NTDs, it does not provide a specific amount for global health security and family planning and reproductive health programs. Comparisons with the Senate bill are in Table 1.


How Does Medical Inflation Compare to Inflation in the Rest of the Economy?

Authors: Shameek Rakshit, Emma Wager, Paul Hughes-Cromwick, Zachary Levinson, and Lynne Cotter
Published: Nov 18, 2026

Medical care prices and overall health spending historically outpace growth in the rest of the economy. Health costs represent a growing share of gross domestic product, and many American families have seen the costs of health services and health insurance premiums grow faster than their wages. Between January 2000 and October 2026, medical care prices grew 33% more than overall consumer prices, with the price of hospital services experiencing the fastest growth.

This KFF analysis describes both short-term and long-term inflation trends to provide a more nuanced understanding of how healthcare price growth compares to price growth in the rest of the economy.

The analysis primarily examines inflation in prices by urban consumers using Consumer Price Index for All Urban Consumers (CPI-U) data from the Bureau of Labor Statistics (BLS). This analysis and others can be found on the Peterson-KFF Health System Tracker, an information hub dedicated to monitoring and assessing the performance of the U.S. health system.

Key Global Health Positions and Officials in the U.S. Government

Published: Nov 17, 2026

This tracker is updated periodically based on publicly available information.

PositionOfficial
WHITE HOUSE/EXECUTIVE OFFICE OF THE PRESIDENT
National Security Advisor/Assistant to the President for National Security Affairs, National Security Council (NSC)Marco Rubio
Director, Office of National AIDS Policy (ONAP)Vacant
Director, Office of Management and Budget (OMB)Russ Vought
U.S. Trade Representative, Office of the United States Trade Representative (USTR)Jamieson Greer
Director, Office of Science and Technology Policy (OSTP)Michael Kratsios
Director, Office of Pandemic Preparedness and Response Policy (OPPR)Sara Brenner
U.S. Coordinator for Global Health SecurityVacant
DEPARTMENT OF STATE
Secretary of StateMarco Rubio
Permanent U.S. Representative to the United Nations, U.S. Mission to the United NationsMike Waltz
Senior Official, Under Secretary for Foreign Assistance, Humanitarian Affairs and Religious FreedomAndrew Veprek
Ambassador-at-Large for Global Health Security and DiplomacyJohnny Figueroa (Designate)
Global AIDS Coordinator, Bureau of Global Health Security and DiplomacyJohnny Figueroa (Designate)
Jeffrey Graham
Principal Deputy Assistant Secretary for Global Health Security and Diplomacy; Deputy Assistant Secretary for PEPFAR and Health Programs, Bureau of Global Health Security and DiplomacyHillary Carter
Senior Advisor for Global Health Security and Diplomacy, Bureau of Global Health Security and DiplomacyBrad Smith
Assistant Secretary, Bureau of Democracy, Human Rights, and LaborRiley Barnes
Senior Bureau Official, Bureau of Population, Refugees, and MigrationAdam Zerbinopoulous
Senior Bureau Official, Bureau of International Organization AffairsMcCoy Pitt
Assistant Secretary, Bureau of Oceans and International Environmental and Scientific Affairs (OES)Wesley Brooks
DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS)
SecretaryRobert F. Kennedy Jr. 
Director, Office of Global Affairs (OGA)Bethany Kozma
Assistant Secretary for HealthBrian Christine
Surgeon GeneralNicole Saphier (Designate)
Stephanie Haridopolos
Principal Deputy Assistant Secretary for Preparedness and Response, Administration for Strategic Preparedness and Response (ASPR)Sean Kaufman
Director, Center for the Biomedical Advanced Research and Development Authority (BARDA), ASPRGary Disbrow
HHS/CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC)
DirectorErica Schwartz
Deputy Director for Global HealthMatthew Ferreira
Director, Office of Readiness and ResponseHenry Walke
Director, Washington OfficeAnstice Brand Kenefick
Director, Global Health Center (GHC)John Vertefeuille
Director, Division of Global Health Protection, GHCBenjamin Park
Director, Division of Global HIV and TB, GHCHank Tomlinson
Director, Global Immunization Division, GHCJohn Vertefeuille
Director, Division of Parasitic Diseases and Malaria, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)Simon Agolory
Director, Influenza Division, National Center for Immunization and Respiratory Diseases (NCIRD)Vacant
HHS/NATIONAL INSTITUTES OF HEALTH (NIH)
DirectorJay Bhattacharya
Director, National Institute of Allergy and Infectious Diseases (NIAID)John Powers III
Director, Office of Global Research, NIAIDJoyelle Dominique
Director, Division of AIDS, NIAIDRobert Eisinger
Director, Division of Microbiology and Infectious Diseases (DMID), NIAIDDavid Spiro
Director, Vaccine Research Center, NIAIDTed Pierson
Director, Office of AIDS Research (OAR); NIH Associate Director for AIDS ResearchGeri Donenberg
Director, Fogarty International Center (FIC); NIH Associate Director for International ResearchSteven Schiff
Director, Center for Global Health, Office of the Director, National Cancer InstituteSatish Gopal
Director, Office of Global Health, Office of the Director, National Institute of Child Health and Human DevelopmentVesna Kutlesic
Director, Center for Global Mental Health Research, National Institute of Mental HealthLeonardo Cubillos
HHS/FOOD & DRUG ADMINISTRATION (FDA)
CommissionerKyle Diamantas
Deputy Commissioner for Policy, Legislation, and International AffairsGrace Graham
Associate Commissioner for Global Policy and StrategyMark Abdoo
HHS/HEALTH RESOURCES AND SERVICES ADMINISTRATION (HRSA)
AdministratorThomas Engels
Associate Administrator, Bureau of HIV/AIDSHeather Hauck
Director, Office of Global Health, Office of Special Health InitiativesMelissa Ryan Kemburu
DEPARTMENT OF DEFENSE (DoD)
SecretaryPete Hegseth
Assistant Secretary of Defense for Health Affairs, Personnel and Readiness (P&R)Keith Bass
Commander, Naval Medical Research Command (NMRC)Eric Welsh
Director, DoD HIV/AIDS Prevention Program (DHAPP)Brad Hale
Commander, Walter Reed Army Institute of Research (WRAIR)Brianna Perata
Director, U.S. Military HIV Research Program (MHRP)Julie Ake
Chief, Armed Forces Health Surveillance Division (AFHSD)Richard Langton
Chief, Global Emerging Infections Surveillance (GEIS), AFHSDBrett Swierczewski
OTHER AGENCIES AND DEPARTMENTS
Peace Corps*: DirectorChristopher Landau
Council of the Inspectors General on Integrity and Efficiency*: Chair, Pandemic Response Accountability CommitteeWilliam Kirk
Council of the Inspectors General on Integrity and Efficiency*: Executive Director, Pandemic Response Accountability CommitteeKenneth Dieffenbach
Department of Agriculture (USDA): SecretaryBrooke Rollins
Environmental Protection Agency (EPA)*: Assistant Administrator for International and Tribal AffairsUsha-Maria Turner
Department of Homeland Security (DHS): Chief Medical OfficerSean Conley
U.S. Executive Director, World BankLailee Moghtader
Notes: Acting officials in italics. Officials who the White House has signaled it intends to nominate or who are formally awaiting Senate confirmation are noted as “Designate.” tbd means to be determined. As of November 10, 2026. Also see NIH/FIC, Global Health Initiatives at NIH, available at: https://www.fic.nih.gov/Global/Global-Health-NIH/Pages/institute-center-ics-global-health.aspx.